Generic selectors
Exact matches only
Search in title
Search in content

Improving and increasing diversity, equity, and inclusion in the digitized clinical trial design process

Today’s clinical trials fail to represent the diversity of the general population or those with specific diseases. However, digital approaches offer a new suite of opportunities to improve diversity, equity, and inclusion in clinical trials. This project aims to ensure that the promise of easier access, broader inclusion, and more generalizable findings is finally realized.

Project Goal

Ensure that the digitization of clinical trials results in a more accessible and inclusive clinical research enterprise that produces more generalizable findings, and extends the benefits of new medical products to all members of the population. 

Primary Objective

Develop best practices, pragmatic resources, and educational materials that will support life science companies in designing clinical trials that successfully engage, enroll and retain underrepresented populations.

Our Model


Diversity, Equity, and Inclusion in Digitized Clinical Trials: Our Partners

The DiMe Diversity, Equity, and Inclusion in Digitized Clinical Trials project will develop the best practices necessary to harness the promise of digital transformation of clinical trials to benefit all individuals, not just the over-represented few. 

Diversity of data is a critical factor for advancing healthcare; this will only be achieved through equitable practices that ensure more inclusivity of underrepresented and underserved populations, in all steps of the clinical trials process, including recruitment, conduct, and data analysis.

We are proud to bring together life science companies; diversity, equity, and inclusion experts; and other leaders from the health-tech continuum together in this pre-competitive environment to advance the field for all.


DiMe and our project partners are committed to clinical quality work on a tech timeline.
Action-oriented resources will be launched in early 2023.


Diversity, Equity, and Inclusion in Digitized Clinical Trials: In The News


Digital medicine is the future. Build it with us. 

DiMe’s projects are seeded by our member community, where experts share the greatest barriers to advancing the field of digital medicine. When the most complex and significant roadblocks can be addressed with a cross-ecosystem, pre-competitive approach, that’s where we come in: DiMe convenes multi-stakeholder teams to quickly dive deep into issues and rapidly produce high-quality resources that meaningfully enable progress.

Join DiMe and become a part of the growing community that is advancing the safe, effective, equitable, and ethical use of digital medicine to optimize human health.

Copyright © 2022 The Digital Medicine Society (DiMe). All Rights Reserved.